PubRank

J L McCoy

Author PubWeight™ 49.70‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Induction and regression of primary moloney sarcoma virus-induced tumors in mice. Cancer Res 1967 1.60
2 Antigenicity of a virus-induced murine sarcoma (Moloney). Cancer Res 1967 1.58
3 Immunologic, virologic, and pathologic studies of regression of autochthonous Moloney sarcoma virus-induced tumors in mice. Cancer Res 1968 1.57
4 Lymphocyte cytotoxicity reactions to leukemia-associated antigens in identical twins. Int J Cancer 1972 1.55
5 Natural cytotoxicity of mouse monocytes and macrophages. J Immunol 1979 1.43
6 Cross-resistance to the transplantation of syngeneic Friend, Moloney, and Rauscher virus-induced tumors. Cancer Res 1968 1.39
7 Destruction of human lymphoid tissue-culture cell lines by human peripheral lymphocytes in 51Cr-release cellular cytotoxicity assays. J Natl Cancer Inst 1974 1.36
8 Comparative studies on the induction of transplantation resistance in BALB-c and C57BL-6 mice in three murine leukemia systems. Cancer Res 1967 1.22
9 Contextual and sociodemographic antecedents of institutionalization among aged welfare recipients. Med Care 1981 1.18
10 In vitro human reactivity to staphylococcal phage lysate. J Immunol 1975 1.09
11 Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma. J Natl Cancer Inst 1975 1.09
12 Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human breast carcinoma. J Natl Cancer Inst 1974 1.02
13 51 Chromium-release assay for cell-mediated cytotoxicity of human leukemia and lymphoid tissue-culture cells. Natl Cancer Inst Monogr 1973 0.99
14 Role of suppressor cells in depression of in vitro lymphoproliferative responses of lung cancer and breast cancer patients. J Natl Cancer Inst 1978 0.99
15 Reactivity of lung cancer patients in leukocyte migration inhibition assays to 3-M potassium chloride extracts of fresh tumor and tissue-cultured cells derived from lung cancer. J Natl Cancer Inst 1977 0.97
16 Immunological monitoring and immunotherapy in carcinoma of the lung. Int J Cancer 1976 0.97
17 Evaluation of a cell-mediated cytotoxicity assay utilizing 125 iododeoxyuridine-labeled tissue-culture target cells. Natl Cancer Inst Monogr 1973 0.95
18 Cryopreservation of human lymphocyte function as measured by in vitro assays. Int J Cancer 1976 0.95
19 The relative proliferation index as a more sensitive parameter for evaluating lymphoproliferative responses of cancer patients to mitogens and alloantigens. Int J Cancer 1977 0.93
20 Conditions for generating and assaying human leukocyte inhibitory factor (LIF) induced by purified protein derivative (PPD). Immunopharmacology 1978 0.91
21 Studies on the neutralization of the oncogenicity of Friend, Moloney, and Rauscher viruses. Cancer Res 1968 0.91
22 Refractoriness to migration inhibitory factor of macrophages of LPS nonresponder mouse strains. J Immunol 1978 0.87
23 Cellular immunity to mammary tumor virus in normal and tumor-bearing C3H/HeN mice. Cancer Res 1978 0.87
24 Evaluation of lymphocyte immunity in breast cancer patients. Breast Cancer Res Treat 1993 0.87
25 Lymphocytes forming rosettes with sheep erythrocytes in metastatic pleural effusions. J Natl Cancer Inst 1976 0.86
26 Income and living arrangements among poor aged singles. Soc Secur Bull 1981 0.85
27 Immunogenicity, antigenicity and mechanisms of tumor rejection of mineral-oil-induced plasmacytomas in syngeneic BALB/c mice. Int J Cancer 1974 0.85
28 Development of cell-mediated antiviral immunity and macrophage activation in C3H/HeN mice infected with mouse mammary tumor virus. J Immunol 1980 0.85
29 Human cell-mediated immunity to tuberculin as assayed by the agarose micro-droplet leukocyte migration inhibition technique: comparison with the capillary tube assay. J Immunol Methods 1977 0.85
30 Studies on the growth and regression of a transplantable Moloney sarcoma. Cancer Res 1967 0.84
31 Cell-mediated immunity to melanoma-associated antigens in patients with ocular malignant melanoma. Am J Ophthalmol 1975 0.84
32 Immunobiological studies of tumors induced by murine sarcoma virus (Kirsten). Cancer Res 1972 0.84
33 Geographic patterns of disability in the United States. Soc Secur Bull 1994 0.84
34 Examination of general and tumor-specific cell-mediated immune responses in mice bearing progressively growing plasmacytomas. J Natl Cancer Inst 1977 0.83
35 Protective effects of interferon in mice previously exposed to lethal irradiation. Radiat Res 1980 0.83
36 Immunologic and virologic studies of a nonproducer tumor induced by murine sarcoma virus (Harvey). J Natl Cancer Inst 1972 0.82
37 Cell-mediated immunity against particulate and solubilized tumor-associated antigens of murine plasmacytomas detected by macrophage migration inhibition assays. Int J Cancer 1977 0.82
38 Brief communication: technical modifications of the human agarose microdroplet leukocyte migration inhibition assay. J Immunol Methods 1978 0.82
39 Leukocyte migration inhibition by soluble extracts of MCF-7 tissue culture cell line derived from breast carcinoma. J Natl Cancer Inst 1976 0.81
40 Immunologic relationship between breast carcinoma and benign breast disease as detected by the leukocyte migration inhibition assay. J Natl Cancer Inst 1978 0.81
41 Production and characterization of supernatants with high titers of human leukocyte inhibitory factor (LIF). J Immunol 1980 0.80
42 Cellular immunity to tumor-associated antigens of transplantable mammary tumors of C3H/HeN mice. Cancer Res 1979 0.79
43 Migration inhibition by an agarose microdroplet assay: monitoring of tumor-associated antigens on a simian virus 40-induced sarcoma. J Immunol 1977 0.78
44 Influence of infectious virus on the induction of transplantation resistance in the Friend tumor system. Cancer Res 1967 0.78
45 Delayed cutaneous hypersensitivity reactions to extracts of human tumors. Natl Cancer Inst Monogr 1973 0.78
46 Predictors of mortality among newly retired workers. Soc Secur Bull 1991 0.77
47 Immunological reactions to tumor-associated antigens in Burkitts lymphoma and other lymphomas. Cancer Res 1974 0.77
48 Comparison of estrogen and progesterone receptor status to lymphocyte immunity against tumor antigens in breast cancer patients. Breast Cancer Res Treat 1994 0.77
49 Cell-mediated immune responses of breast cancer patients to autologous tumor-associated antigens. J Natl Cancer Inst 1977 0.77
50 Cell-mediated immunity to mouse mammary tumor virus antigens by patients with hyperplastic benign breast disease. J Natl Cancer Inst 1982 0.77
51 Neutralization of the oncogenicity of Moloney sarcoma virus and Moloney leukemia virus by anti-Gross serum. Int J Cancer 1967 0.77
52 Relationship of serum and tumor levels of iron and iron-binding proteins to lymphocyte immunity against tumor antigen in breast cancer patients. Breast Cancer Res Treat 1994 0.76
53 Use of the leukocyte migration inhibition assay to evaluate antigenic differences in human breast cancers and melanomas. J Natl Cancer Inst 1978 0.75
54 Antecedents of mortality among the old-age assistance population. Soc Secur Bull 1979 0.75
55 Studies of lymphocyte stimulation by intact tumor-cell and solubilized tumor antigen. Int J Cancer 1975 0.75
56 Immunologic monitoring in carcinoma of the breast. Surg Gynecol Obstet 1977 0.75
57 Cell-mediated and humoral immunity studies of murine and hamster sarcoma virus-induced producer and non-producer tumors in syngeneic animals. Int J Cancer 1974 0.75
58 Dose-response relationship in skin sensitization. Food Chem Toxicol 1994 0.75
59 Cellular immunity to SV40-induced tumor cells and solubilized tumor-associated antigens in immune mice using an isotopic footpad assay. Int J Cancer 1977 0.75
60 Cellular immune reactions to human leukemia. Natl Cancer Inst Monogr 1972 0.75
61 Assessment of immunologic competence and host reactivity against tumor antigens in breast cancer patients. Prognostic value and rationale of immunotherapy development. Ann N Y Acad Sci 1993 0.75
62 Variation among mouse strains in responsiveness to migration inhibitory factor. Cell Immunol 1979 0.75
63 Restorative effects of levamisole on cell-mediated immune responses following chemotherapy with aniline mustard in mice bearing ADJ-PC5 plasmacytoma. Cancer Treat Rep 1978 0.75
64 Cellular immunity to solubilized tumor antigens of a methylcholanthrene-induced sarcoma with a migration inhibition assay. J Immunol 1978 0.75
65 Experience with mixed leukocyte reactions in immunocompetency evaluations. Prog Clin Biol Res 1984 0.75
66 Humoral and cellular immunity to EBV and lymphoid cell line antigens in human lymphoma. IARC Sci Publ 1975 0.75
67 Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells. J Natl Cancer Inst 1984 0.75
68 Indirect leukocyte migration inhibition reactions to a 3-M KCl extract of lung adenocarcinoma by lung cancer patients. J Natl Cancer Inst 1981 0.75
69 The development of specific cellular and humoral immunity in mice infected with Rauscher leukemia virus as neonates or adults. Cancer Res 1972 0.75
70 Dissociation of depressed general immunocompetence and anti-tumor immunity in plasmacytoma-bearing mice demonstrating suppressor cell activity. Cell Mol Biol Incl Cyto Enzymol 1980 0.75
71 Cellular immune reactivity in vitro and tumor rejection provided by tumor-associated antigens of friend-virus-induced leukemia. Int J Cancer 1975 0.75
72 Phagocyte function evaluation following exposure to test agents. Prog Clin Biol Res 1984 0.75
73 High incidence of migration inhibition reactivity to lung tumor-associated antigen by normal donors in close contact with lung cancer patients or materials. J Natl Cancer Inst 1980 0.75
74 Health status among low-income elderly persons: rural-urban differences. Soc Secur Bull 1978 0.75
75 Cell-mediated immunity in mice against papain-solubilized histocompatibility and tumor-specific antigens by a macrophage migration inhibition microassay. J Natl Cancer Inst 1976 0.75
76 Quantitation of immunocompetence in patients with lung cancer. Surg Forum 1977 0.75
77 Cell-mediated immunity in human acute leukemia. Bibl Haematol 1975 0.75
78 Leukocyte migration inhibition and lymphocyte blastogenesis responses in breast carcinoma patients to mouse mammary tumor virus and to virion gp52 antigen and Rauscher murine leukemia virus-Kirsten sarcoma virus gp69/71 antigen. J Natl Cancer Inst 1978 0.75
79 Leukocyte migration inhibition of tumor antigen and purified protein derivative reactivity in guinea pigs sensitized to line 10 hepatocarcinoma and BCG. J Natl Cancer Inst 1978 0.75
80 Leukocyte migration inhibition in patients with Ewing's sarcoma by 3-M potassium chloride extracts of fresh and tissue-cultured Ewing's sarcomas. J Natl Cancer Inst 1977 0.75
81 Letter: Tumor-associated antigen in female and male breast cancer. N Engl J Med 1975 0.75